Anthera Pharmaceuticals (OTCMKTS:ANTH) Shares Pass Above Two Hundred Day Moving Average of $0.04

Shares of Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.04 and traded as high as $0.08. Anthera Pharmaceuticals shares last traded at $0.07, with a volume of 30,057 shares.

The stock has a 50 day simple moving average of $0.09 and a 200-day simple moving average of $0.04.

Anthera Pharmaceuticals Company Profile (OTCMKTS:ANTH)

Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy.

Featured Article: How does quantitative easing work?

Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit